PAREXEL RECIST 1.1
source

PAREXEL RECIST 1.1

(1)
Price
Free
Category
Medical Reference
Last update
May 30, 2021
Publisher
PAREXEL International Corporation Contact publisher
View in store
Loading...

Ratings & Reviews performance

Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.

Number of reviews,
total
1
Avg rating,
total
⭐4.0
Loading...

Description

279 chars

Learn about RECIST 1.1 and how it can be applied to your clinical trial. RECIST (Response Evaluation Criteria In Solid Tumors) is a set of published rules that define when cancer patients improve ("respond"), stay the same ("stable") or worsen ("progression") during treatments.

Screenshots

https://is4-ssl.mzstatic.com/image/thumb/Purple60/v4/26/fe/62/26fe626d-d9ee-7e1b-1f33-b3c623e782b8/mzl.zdformyw.png/640x1136bb.pnghttps://is2-ssl.mzstatic.com/image/thumb/Purple18/v4/c8/1b/50/c81b500f-185a-b0d0-8cc8-3162b361780f/mzl.gmxuyxiz.png/640x1136bb.pnghttps://is2-ssl.mzstatic.com/image/thumb/Purple20/v4/12/9a/23/129a2379-af6a-d936-c1c5-0fde82ba58f4/mzl.esoreour.png/640x1136bb.pnghttps://is3-ssl.mzstatic.com/image/thumb/Purple18/v4/cd/35/a5/cd35a55c-0ff2-63d9-4249-570f365c568a/pr_source.png/640x1136bb.pnghttps://is1-ssl.mzstatic.com/image/thumb/Purple30/v4/f7/c8/0e/f7c80e5f-b699-4ee9-fa1a-02ed4c594d78/pr_source.png/640x1136bb.png
Loading...
Loading...

Find growth insights on our blog

React to user feedback and market trends faster